The clinical application of the serum pepsinogen I and II levels as a mass screening method for gastric cancer.
Miki
K
K
First Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Japan.
Ichinose
M
M
Kakei
N
N
Yahagi
N
N
Matsushima
M
M
Tsukada
S
S
Ishihama
S
S
Shimizu
Y
Y
Suzuki
T
T
Kurokawa
K
K
D000328:Adult; D000367:Age Factors; D000368:Aged; D015415:Biomarkers / Q000097:blood; D006801:Humans; D015994:Incidence; D007564:Japan / Q000453:epidemiology; D008403:Mass Screening / Q000379:methods*; D008875:Middle Aged; D010435:Pepsinogens / Q000097:blood*; D013276:Stomach Ulcer / Q000175:diagnosis* / Q000453:epidemiology / Q000517:prevention & control; D013997:Time Factors
D015415:Biomarkers; D010435:Pepsinogens